| ₹ crore | Q1 FY27 | Q1 FY26 | Change |
|---|---|---|---|
| Revenue | 29.6 | 16.3 | +81.8% |
| EBITDA | 0.6 | −0.2 | — |
| EBITDA margin | 1.9% | −1.5% | +3.3 pts |
| Profit before tax | 2.1 | −2.1 | — |
| Net profit | 2.1 | −2.1 | — |
| EPS | ₹0.57 | −₹0.55 | — |
Amounts on the left scale in ₹ crore; per cent on the right, dashed. L = lakh crore, K = thousand crore. Touch the chart to read any period.
| Tap a line for its trend | Currentlast 12M | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 100 | — | — | — | — | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 0.7 | 0.7 | 1.2 | 0.5 | 1.8 | ||
| 147 | 147 | 277 | 700 | 707 | ||
| 247 | — | — | — | — | ||
| 161 | 148 | 86.4 | 95.1 | 82.5 | ||
| — | +70.9% | −9.2% | +15.2% | — | ||
| −5.7 | −6.5 | 4.1 | 14.7 | 11.4 | ||
| −3.6% | −4.4% | 4.8% | 15.5% | 13.8% | ||
| −10.5 | −12.0 | −1.9 | 8.4 | 4.7 | ||
| 84.8 | 80.7 | 365 | −4.6 | −4.1 | ||
| 52.7% | 54.7% | 422.2% | −4.8% | −5.0% | ||
| ₹22.87 | ₹21.76 | ₹98.39 | −₹1.23 | −₹1.12 | ||
| — | −77.9% | +8,105.2% | −10.1% | — | ||
| — | −65.5 | 439 | 28.2 | 21.5 | ||
| −65.5 | −65.5 | 439 | 28.2 | 21.5 | ||
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
In ₹ Crore except Per Share 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Current/LTM TTM · last close | |
|---|---|---|---|---|---|---|
| Market Capitalization | — | — | — | — | 100.3 | |
| - Cash, Equiv & ST Investments | 1.8 | 0.5 | 1.2 | 0.7 | 0.7 | |
| + Total Debt | 707.0 | 700.2 | 276.7 | 147.3 | 147.3 | |
| Enterprise Value | — | — | — | — | 246.9 | |
| Revenue | 82.5 | 95.1 | 86.4 | 147.6 | 160.9 | |
| Growth %, YoY | — | +15.2 | -9.2 | +70.9 | — | |
| EBITDA | 11.4 | 14.7 | 4.1 | -6.5 | -5.7 | |
| Margin % | 13.80 | 15.48 | 4.77 | -4.41 | -3.55 | |
| EBIT | 4.7 | 8.4 | -1.9 | -12.0 | -10.5 | |
| Net Income | -4.1 | -4.6 | 364.8 | 80.7 | 84.8 | |
| Margin % | -5.02 | -4.79 | 422.21 | 54.65 | 52.69 | |
| EPS, Adj (current shares) | -1.12 | -1.23 | 98.39 | 21.76 | 22.87 | |
| Growth %, YoY | — | -10.1 | +8,105.2 | -77.9 | — | |
| Cash from Operations | 21.5 | 28.2 | 438.9 | -65.5 | — | |
| Free Cash Flow | 21.5 | 28.2 | 438.9 | -65.5 | -65.5 | |
Prices at the 30 October 2026 close · figures from the company's filings with NSE
Kohinoor Foods (NSE: KOHINOOR) had a market capitalisation of ₹92.7 crore at the 30 October 2026 close (₹25.02 a share) and a PE ratio of 1.1 on the last four quarters' profit. In FY26 its consolidated net profit was ₹80.7 crore on revenue of ₹148 crore; in Q1 FY27 (April–June 2026) it was ₹2.1 crore. Its net worth was negative (−₹93.9 crore) on 31 March 2026, with borrowings of ₹147 crore. Promoters held 37.67% of the shares on 30 September 2026.
Kohinoor Foods' PE ratio is 1.1 at the 30 October 2026 close (₹25.02 a share): a market capitalisation of ₹92.7 crore divided by consolidated net profit of ₹84.8 crore over the last four quarters (Q2 FY26 to Q1 FY27). On FY26 net profit (₹80.7 crore) it is 1.1. These four quarters include net exceptional items of ₹96 crore (one-off gains reported separately), so the ratio on recurring profit would differ.
Kohinoor Foods' return on equity is not meaningful for FY26: shareholders' equity was negative (−₹93.9 crore on 31 March 2026), and a return on a negative base has no sign that can be read. Its return on capital employed (ROCE) was 31.8% — operating profit (EBIT) divided by average capital employed (total assets less current liabilities).
On 30 September 2026, Kohinoor Foods' shares were held by promoters 37.67%, foreign portfolio investors (FII/FPI) 0.01%, domestic institutions (DII) 0.00% and retail and other non-institutional investors 62.31%. Over the year, FII holding was unchanged and DII holding was unchanged.
Kohinoor Foods' market capitalisation was ₹92.7 crore at the 30 October 2026 close: 3.71 crore shares at ₹25.02 each.
No. Kohinoor Foods had borrowings of ₹147 crore on 31 March 2026 (consolidated balance sheet). Its cash and current investments were ₹67 lakh, so its net debt was ₹147 crore.
Kohinoor Foods' basic earnings per share (EPS) were ₹21.75 in FY26, against ₹98.35 in FY25. Over the last four quarters (Q2 FY26 to Q1 FY27) they add up to ₹22.87.
Kohinoor Foods' debt-to-equity ratio is not meaningful: its total equity was negative (−₹93.9 crore) on 31 March 2026, against borrowings of ₹147 crore. A negative equity means accumulated losses exceed the capital shareholders put in.
Kohinoor Foods' net worth was negative on 31 March 2026: shareholders' equity of −₹93.9 crore in its consolidated balance sheet, meaning accumulated losses exceed the capital put in. The market still values the company at ₹92.7 crore (market capitalisation at the 30 October 2026 close).
Kohinoor Foods' latest results are for Q1 FY27 (April–June 2026), filed on 13 August 2026: consolidated net profit ₹2.1 crore, against a loss of ₹2.1 crore in Q1 FY26; revenue from operations ₹29.6 crore, up 81.8% year on year.
Promoters held 37.67% of Kohinoor Foods on 30 September 2026, unchanged from both the previous quarter and a year earlier, according to the shareholding pattern filed with NSE.
In FY26, Kohinoor Foods generated ₹65.5 crore of cash from operations and spent ₹0 lakh on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of −₹65.5 crore. In FY25 it was ₹439 crore.
Kohinoor Foods has not yet announced the date of its Q2 FY27 results (July–September 2026); under SEBI's listing rules (Regulation 33) they are due by 14 November 2026.
In FY26 (April 2025–March 2026), Kohinoor Foods' consolidated net profit was ₹80.7 crore, down 77.9% from ₹365 crore in FY25, on revenue from operations of ₹148 crore (up 70.9%).
On FY26 consolidated figures, against Indo Us Biotech and Nath Bio-Genes: Kohinoor Foods' operating margin of −8.1% is the lowest of the three (Indo Us Biotech 14.6%, Nath Bio-Genes 10.9%; peer average 12.7%).
At the 30 October 2026 closing prices, on FY26 net profit, Kohinoor Foods' PE ratio is 1.1, the lowest of the three: Indo Us Biotech 11.2 and Nath Bio-Genes 6.0, a peer average of 8.6. Each is the company's market capitalisation at that price divided by its FY26 net profit.
In FY26, Kohinoor Foods earned net profit of ₹80.7 crore on revenue of ₹148 crore, against ₹13.1 crore on ₹110 crore for Indo Us Biotech. Kohinoor Foods' operating margin was −8.1% (Indo Us Biotech 14.6%). At the 30 October 2026 close, Kohinoor Foods' market capitalisation was ₹92.7 crore against ₹147 crore for Indo Us Biotech, and its PE ratio on FY26 profit 1.1 against 11.2.
From Kohinoor Foods' own consolidated results, balance sheets and shareholding patterns filed with NSE, and NSE prices (the latest used here: the 30 October 2026 close). Ratios are calculated by Alphave from those filings as each answer describes.
Consolidated figures from the company's filings with NSE; prices are NSE closing prices.